Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 6/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.76 |
| ▸ | LMNA | P02545 | 4/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.76 |
| ▸ | PDE4A | P27815 | 1/20 | 0.71 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | AKT1 | P31749 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfametomidine SCHEMBL151238 | 1.00 | HTR6 (0.76) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| Sulfametomidine SCHEMBL11123046 | 0.99 | ALDH1A1 (0.74) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| Sulfametomidine SCHEMBL13723980 | 0.89 | LMNA (0.70) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| Sulfametomidine SCHEMBL28142816 | 0.88 | KMT2A (0.71) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| SCHEMBL7837632 | 0.88 | HTR6 (0.78) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| Sulfadimethoxine SCHEMBL93845 | 0.86 | LMNA (1.00) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| Sulfadimethoxine SCHEMBL29363944 | 0.86 | LMNA (1.00) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| Sulfadimethoxine SCHEMBL2430279 | 0.85 | LMNA (0.97) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| SCHEMBL7833927 | 0.84 | HTR6 (0.72) | HTR6ALDH1A1LMNACYP3A4PDE4A | |
| Sulfisomidine SCHEMBL34791 | 0.83 | PDE4A (1.00) | HTR6ALDH1A1LMNACYP3A4PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120022878-A | Amphiphilic covalent organic framework mixed mode chromatographic stationary phase and preparation method and application thereof | 河南工业大学 | 2025-05-23 | — | — | CN | claimed |
| CN-118771578-B | Method for degrading new pollutants based on amino-modified iron coordination polymer activated peroxyacetic acid | 同济大学 | 2025-01-21 | — | — | CN | claimed |
| CN-110891562-B | Lithium salts of N-substituted glycine compounds and uses thereof | 心悦生医股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-113365623-B | Antiandrogens for the treatment of metastatic castration-sensitive prostate cancer | 阿拉贡药品公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-115667235-B | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | 卡鲁娜治疗学有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-120022878-A | Amphiphilic covalent organic framework mixed mode chromatographic stationary phase and preparation method and application thereof | 河南工业大学 | 2025-05-23 | — | — | CN | disclosed |
| CN-116209446-B | 7- (Piperidin-1-yl) -4H-pyrimido [1,2-B ] pyridazin-4-one derivatives as positive allosteric modulators of muscarinic acetylcholine receptor M4 | 范德堡大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-110573184-B | RNA nanostructures, methods of making and uses thereof | 俄亥俄州立创新基金会 | 2025-05-13 | — | — | CN | disclosed |
| CN-112424197-B | Difluoromethyl-phenyltriazoles as modulators of GABA receptors | 勃林格殷格翰国际公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119855901-A | Tiling receptor-ligand reprogramming chemotaxis via display peptides | 加利福尼亚大学董事会 | 2025-04-18 | — | — | CN | disclosed |
| CN-119613404-A | Organic compound | 细胞内治疗公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-110740993-B | Deuterated pyridonamides and prodrugs thereof useful as sodium channel modulators | 沃泰克斯药物股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-111848577-B | N- (hetero) aryl-substituted heterocyclic derivatives useful in the treatment of diseases or conditions associated with the central nervous system | 克罗诺斯治疗有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116600803-A | Macrocyclic urea orexin receptor agonists | 默沙东有限责任公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-116490180-A | Methods of treating CNS disorders | 杭州高光制药有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-111093664-B | Organic compound | 细胞内治疗公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-116209446-A | 7- (piperidin-1-yl) -4H-pyrimido [1,2-B ] pyridazin-4-one derivatives as positive allosteric modulators of muscarinic acetylcholine receptor M4 | 范德堡大学 | 2023-06-02 | — | — | CN | disclosed |
| CN-116178391-A | Forward allosteric modulators of muscarinic acetylcholine receptor M4 | 范德比尔特大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-116041365-A | Muscarinic acetylcholine receptorsBody M 4 Positive allosteric modulators of (2) | 范德比尔特大学 | 2023-05-02 | — | — | CN | disclosed |
| CN-112118831-B | Tabletted chewing gum sweet suitable for active pharmaceutical ingredient | 费尔廷制药公司 | 2023-04-21 | — | — | CN | disclosed |